KRT43P

Across TCGA pan-cancer cohorts, KRT43P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated KRT43P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher KRT43P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRT43P expression acts as an unfavorable survival marker, although some lineages such as BRCA and STAD show a favorable association.

LIHC, GBM, and KIRC are the cancer types where KRT43P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.210	0.723	<.001	54	view →
GBM	OS	Tertile	All	0.235	0.433	.001	36	view →
KIRC	DFS	Tertile	III,IV	0.168	0.506	.003	36	view →
CESC	OS	Quartile	IV	0.157	0.688	<.001	36	view →
THYM	OS	Tertile	All	0.696	1.000	<.001	36	view →
HNSC	DFS	Quartile	All	0.540	0.668	.014	16	view →
BLCA	DFS	Tertile	All	0.108	0.364	.026	15	view →
BRCA	OS	Tertile	II,III,IV	0.957	0.903	.023	15	view →
STAD	DFS	Quartile	IV	1.000	0.293	.009	13	view →
READ	OS	Tertile	III,IV	0.776	0.392	.020	11	view →
COAD	DFS	Quartile	All	0.773	0.464	.039	5	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

KRT43P–LIHC (OS)

Open the LIHC breakdown →